Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary

Environment International

Volumn 54, Issue , 2013, Pages 92-99

  Klosterhaus, Susan L ^a   Grace, Richard ^b   Hamilton, M Coreen ^b   Yee, Donald ^a  

^a SAN FRANCISCO ESTUARY INSTITUTE   (United States)

^b AXYS Analytical Services Ltd   (Canada)

Author keywords

Alkylphenol; Bioaccumulation; Mussels; Pharmaceutical; San Francisco Bay

Indexed keywords

BIOACCUMULATION; BIOCHEMISTRY; DISCHARGE (FLUID MECHANICS); DRUG PRODUCTS; ESTUARIES; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHENOLS; SEDIMENTOLOGY; SEDIMENTS; SHELLFISH; TISSUE;

ALKYL PHENOLS; BIOACCUMULATION FACTOR; DRY WEIGHT; ENVIRONMENTAL SAMPLE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; INDUSTRIAL WASTEWATERS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MAXIMUM CONCENTRATIONS; METHOD VALIDATIONS; MUSSEL TISSUE; MUSSELS; N ,N-DIETHYL-M-TOLUAMIDE; NONYLPHENOLS; NOVEL METHODS; PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; SAN FRANCISCO BAY; TOXIC EFFECT; TRICLOCARBAN; URBAN ESTUARY; VALSARTAN; WET WEIGHT;

MOLLUSCS;

ALKYLPHENOL; AMITRIPTYLINE; ATENOLOL; CAFFEINE; CARBAMAZEPINE; CLARITHROMYCIN; COTININE; DEHYDRONIFEDIPINE; DIAZEPAM; DIETHYLTOLUAMIDE; DIGOXIGENIN; DILTIAZEM; DRUG; ENALAPRIL; ENVIRONMENTAL CHEMICAL; GEMFIBROZIL; NONYLPHENOL; NONYLPHENOL DIETHOXYLATE DERIVATIVE; NONYLPHENOL MONOETHOXYLATE DERIVATIVE; PHARMACEUTICALS AND PERSONAL CARE PRODUCT; PHENOL DERIVATIVE; RANITIDINE; SALBUTAMOL; SERTRALINE; SULFAMETHOXAZOLE; SURFACE WATER; TRIAMTERENE; TRICLOCARBAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN;

BIOACCUMULATION; DRUG; ESTUARINE POLLUTION; ESTUARINE SEDIMENT; MOLLUSC; PHENOL; TOXICITY;

AQUATIC SPECIES; ARTICLE; CONCENTRATION (PARAMETERS); DRY WEIGHT; ESTUARY; INDUSTRIAL WASTE; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MUSSEL; NONHUMAN; PRIORITY JOURNAL; SEDIMENT; TANDEM MASS SPECTROMETRY; TISSUE SECTION; UNITED STATES; URBAN AREA; VALIDATION STUDY; WASTE WATER; WEIGHT; WET WEIGHT;

CALIFORNIA; SAN FRANCISCO BAY; UNITED STATES;

EID: 84873933711     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2013.01.009     Document Type: Article

References (60)

1. Arnot J.A., Gobas F.A.P.C. A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms. Environ Rev 2006, 14:257-297.
2. Batt A.L., Kostich M.S., Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal Chem 2008, 80:5021-5030.
3. Benotti M.J., Brownawell B.J. Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environ Sci Technol 2007, 41:5795-5802.
4. Benotti M.J., Brownawell B.J. Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ Pollut 2009, 157:994-1002.
5. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2009, 43:597-603.
6. Berninger J.P., Brooks B.W. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett 2010, 193:69-78.
7. OW and tissue lipid content as predictors of chemical partitioning to fish tissues. Environ Toxicol Chem 1998, 17:1447-1455.
8. Billinghurst Z., Clare A.S., Fileman T., McEvoy J., Readman J., Depledge M.H. Inhibition of barnacle settlement by the environmental oestrogen 4-nonylphenol and the natural oestrogen 17 beta oestradiol. Mar Pollut Bull 1998, 36:833-839.
9. Boxall, et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ Health Perspect 2012, 120:1221-1229.
10. Brausch J.M., Rand G.M. A review of personal care products in the aquatic environment: environmental concentrations and toxicity. Chemosphere 2010, 82:1518-1532.
11. Brausch J.M., Connors K.A., Brooks B.W., Rand G.M. Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. Rev Environ Contam Toxicol 2012, 218:1-99.
12. Bringolf R.B., Heltsley R.M., Newton T.J., Eads C.B., Fraley S.J., Shea D., et al. Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater mussels. Environ Toxicol Chem 2010, 29:1311-1318.
13. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., et al. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 2005, 24:464-469.
14. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 2010, 44:5619-5626.
15. Burkhardt M.R., ReVello R.C., Smith S.G., Zaugg S.D. Pressurized liquid extraction using water/isopropanol coupled with solid-phase extraction cleanup for industrial and anthropogenic waste-indicator compounds in sediment. Anal Chim Acta 2005, 534:89-100.
16. Coogan M.A., La Point T.W. Snail bioaccumulation of triclocarban, triclosan, and methyltriclosan in a North Texas, USA, stream affected by wastewater treatment plant runoff. Environ Toxicol Chem 2008, 27:1788-1793.
17. Cordova-Kreylos A.L., Scow K.M. Effects of ciprofloxacin on salt marsh sediment microbial communities. Int Soc Microb Ecol 2007, 1:585-595.
18. Daughton C.G., Brooks B.W. Active pharmaceutical ingredients and aquatic organisms. Environmental contaminants in biota: interpreting tissue concentrations 2011, 287-347. Taylor and Francis, Philadelphia, PA. N. Beyer, J. Meador (Eds.).
19. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-937.
20. David A., Fenet H., Gomez E. Alkylphenols in marine environments: distribution monitoring strategies and detection considerations. Mar Pollut Bull 2009, 58:953-960.
21. Dunlavey E., Tucker D., Ervin J. Environmetal fate and transport of microconstituents. Water Environ Technol 2010, 22:42-46.
22. Fair P.A., Lee H.B., Adams J., Darling C., Pacepavicius G., Alaee M., Bossart G.D., Henry N., Muir D. Occurrence of triclosan in plasma of wild Atlantic bottlenose dolphins (Tursiops truncatus) and in their environment. Environ Pollut 2009, 157:2248-2254.
23. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
24. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyerd M.T., Zaugg S.D., et al. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) Untreated drinking water sources. Sci Total Environ 2008, 402:201-216.
25. Fu W., Franco A., Trapp S. Methods for estimating the bioconcentration factor of ionizable organic chemicals. Environ Toxicol Chem 2009, 28:1372-1379.
26. Glassmeyer S.T., Furlong E.T., Kolpin D.W., Cahill J.D., Zaugg S.D., Werner S.L., et al. Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. Environ Sci Technol 2005, 39:5157-5169.
27. Hummel D., Löffler D., Fink G., Ternes T.A. Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ Sci Technol 2006, 40:7321-7328.
28. Jelic A., Petrovic M., Barcelo D. Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadropole-linear ion trap mass spectrometery. Talanta 2009, 80:363-371.
29. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 2008, 42:3498-3518.
30. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Illicit drugs and pharmaceuticals in the environment - forensic applications of environmental data, part 2: pharmaceuticals as chemical markers of fecal water contamination. Environ Pollut 2009, 157:1778-1786.
31. Khetan S.K., Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 2007, 107:2319-2364.
32. Kim S., Carlson K. Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. Environ Sci Technol 2007, 41:50-57.
33. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
34. Langford K., Thomas K.V. Input of selected human pharmaceuticals metabolites into the Norwegian aquatic environment. J Environ Monit 2011, 13:416-421.
35. Loffler D., Rombke J., Meller M., Ternes T.A. Environmental fate of pharmaceuticals in water/sediment systems. Environ Sci Technol 2005, 39:5209-5218.
36. Lubliner B., Redding M., Ragsdale D. Pharmaceuticals and personal care products in municipal wastewater and their removal by nutrient treatment technologies 2010, Washington State Department of Ecology, Olympia, WA, [Publication Number 10-03-004. www.ecy.wa.gov/biblio/1003004.html].
37. Madureira T.V., Barreiro J.C., Rocha M.J., Rocha E., Cass Q.B., Tiritan M.E. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci Total Environ 2010, 408:5513-5520.
38. Martin J., Santos J.L., Aparicio I., Alonso E. Multi-residue method for the analysis of pharmaceutical compounds in sewage sludge, compost and sediments by sonication-assisted extraction and LC determination. J Sep Sci 2010, 33:1760-1766.
39. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A.B.A. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environ Pollut 2012, 165:250-258.
40. Miller T.R., Heidler J., Chillrud S.N., Delaquil A., Ritchie J.C., Mihalic J.N., et al. Fate of triclosan and evidence of reductive dechlorination of triclocarban in estuarine sediments. Environ Sci Technol 2008, 42:4570-4576.
41. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal Chem 2007, 79:3155-3163.
42. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., et al. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ Toxicol Chem 2009, 28:2587-2597.
43. Scherrer R.A., Howard S.M. Use of distribution coefficients in quantitative structure-activity relationships. J Med Chem 1977, 20:53-58.
44. Singh S.P., Azua A., Chaudhary A., Khan S., Willett K.L., Gardinali P.R. Occurrence and distribution of steroids, hormones and selected pharmaceuticals in South Florida coastal environments. Ecotoxicology 2010, 19:338-350.
45. Shultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence, fate in water and sediment, and selective uptake in fish neural tissue. Environ Sci Technol 2010, 44:1918-1925.
46. Soares A., Guieysse B., Jefferson B., Cartmell E., Lester J.N. Nonylphenol in the environment: a critical review on occurrence, fate, toxicity and treatment in wastewaters. Environ Int 2008, 34:1033-1049.
47. Stein K., Ramil M., Fink G., Sander M., Ternes T.A. Analysis and sorption of psychoactive drugs onto sediment. Environ Sci Technol 2008, 42:6415-6423.
48. Tang C., Huang Q., Yu Y., Peng X. Multiresidue determination of sulfonamides, macrolides, trimethoprim, and chloramphenicol in sewage sludge and sediment using ultrasonic extraction coupled with solid phase extraction and liquid chromatography-tandem mass spectrometry. Chin J Anal Chem 2009, 37:1119-1124.
49. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
50. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar Pollut Bull 2004, 49:436-444.
51. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J Chromatogr A 2008, 1177:150-158.
52. US EPA Method 1694: pharmaceuticals and personal care products in water, soil, sediment, and biosolids by HPLC/MS/MS 2007, Office of Water, Office of Science and Technology, Engineering and Analysis Division, [EPA-821-R-08-002].
53. Valenti T.W., Gould G.G., Berninger J.P., Connors K.A., Keele N.B., Prosser K.N., et al. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows. Environ Sci Technol 2012, 46:2427-2435.
54. Vazquez-Roig P., Segarra R., Blasco C., Andreu V., Picó Y. Determination of pharmaceuticals in soils and sediments by pressurized liquid extraction and liquid chromatography tandem mass spectrometry. J Chromatogr A 2010, 1217:2471-2483.
55. Veith G.D., Kosian P. Estimating bioconcentration potential from octanol/water partition coefficients. Physical behaviour of PCBs in the Great Lakes 1983, 269-282. Ann Arbor Science, Ann Arbor, MI. D. Mackay, S. Patterson, S.J. Eisenreich, M.S. Simmons (Eds.).
56. Waiser M.J., Humphries D., Tumber V., Holm J. Effluent dominated streams. Part 2: presence and possible effects of pharmaceuticals and personal care products in Wascana Creek, Saskatchewan, Canada. Environ Toxicol Chem 2011, 30:508-519.
57. Weigel S., Kuhlmann J., Hühnerfuss H. Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine, and DEET in the North Sea. Sci Total Environ 2002, 295:131-141.
58. Wille K., Noppe H., Verheyden K., Vanden Bussche J., De Wulf E., Van Caeter P., et al. Validation and application of an LC-MS/MS method for the simultaneous quantification of 13 pharmaceuticals in seawater. Anal Bioanal Chem 2010, 397:1797-1808.
59. Yang J., Ying G., Zhao J., Tao R., Su H., Chen F. Simultaneous determination of four classes of antibiotics in sediments of the Pearl Rivers using RRLC-MS/MS. Sci Total Environ 2010, 408:3424-3432.
60. Yang Y., Fu J., Peng H., Hou L., Liu M., Zhou J.L. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. J Hazard Mater 2011, 190:588-596.